DK1047704T3 - Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5% - Google Patents

Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%

Info

Publication number
DK1047704T3
DK1047704T3 DK98965703T DK98965703T DK1047704T3 DK 1047704 T3 DK1047704 T3 DK 1047704T3 DK 98965703 T DK98965703 T DK 98965703T DK 98965703 T DK98965703 T DK 98965703T DK 1047704 T3 DK1047704 T3 DK 1047704T3
Authority
DK
Denmark
Prior art keywords
fludarabine phosphate
purity
lithium
potassium
calcium
Prior art date
Application number
DK98965703T
Other languages
English (en)
Other versions
DK1047704T4 (da
Inventor
Ulf Tilstam
Klaus Nickisch
Thomas Schmitz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7852365&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1047704(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK1047704T3 publication Critical patent/DK1047704T3/da
Application granted granted Critical
Publication of DK1047704T4 publication Critical patent/DK1047704T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/19—Purine radicals with arabinosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98965703T 1997-12-11 1998-11-30 Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5% DK1047704T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19756289 1997-12-11
PCT/EP1998/007651 WO1999029710A2 (de) 1997-12-11 1998-11-30 Reinigungsverfahren zur herstellung von fludarabin-phosphat

Publications (2)

Publication Number Publication Date
DK1047704T3 true DK1047704T3 (da) 2003-06-23
DK1047704T4 DK1047704T4 (da) 2008-03-25

Family

ID=7852365

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98965703T DK1047704T4 (da) 1997-12-11 1998-11-30 Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%

Country Status (21)

Country Link
US (2) US6046322A (da)
EP (1) EP1047704B2 (da)
JP (2) JP4261051B2 (da)
KR (2) KR100532898B1 (da)
AT (2) ATE231880T1 (da)
AU (1) AU739574B2 (da)
CA (1) CA2313486A1 (da)
CZ (1) CZ296366B6 (da)
DE (2) DE59807096D1 (da)
DK (1) DK1047704T4 (da)
ES (1) ES2190136T5 (da)
HK (1) HK1033831A1 (da)
HU (1) HU226997B1 (da)
IL (1) IL136283A (da)
NO (1) NO315324B1 (da)
PL (1) PL195712B1 (da)
SI (1) SI1047704T2 (da)
SK (1) SK283475B6 (da)
TW (1) TW424093B (da)
WO (1) WO1999029710A2 (da)
ZA (1) ZA9811338B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59807096D1 (de) 1997-12-11 2003-03-06 Schering Ag Verfahren zur herstellung von fludarabin-phosphat-lithium-, natrium-, kalium-, calcium- und magnesium-salzen, reinigungsverfahren zur herstellung von fludarabin-phosphat und fludarabin-phosphat mit mindestens 99,5 %iger reinheit
KR100381930B1 (ko) * 2000-03-16 2003-04-26 (주)바이오니아 유전자 변형 농산물 검출방법 및 검출용 프라이머
WO2003049764A1 (en) 2001-12-12 2003-06-19 Fh Faulding & Co Limited Composition for viral preservation
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
CA2487070A1 (en) * 2002-05-24 2003-12-04 Sicor Inc. Aqueous fludarabine phosphate composition
EP1464708A1 (en) * 2003-04-03 2004-10-06 Pro. Bio. Sint. S.p.A. A process for the preparation of fludarabine phosphate from 2-fluoroadenine
US7698201B2 (en) * 2006-09-14 2010-04-13 The Prudential Insurance Company Of America Financial instrument utilizing an optional benefit election
CN103040855B (zh) * 2012-12-28 2014-05-14 海南锦瑞制药股份有限公司 一种磷酸氟达拉滨的药物组合物及其制备方法
EP3342778B1 (en) * 2015-08-28 2022-01-12 Zhejiang Hisun Pharmaceutical Co., Ltd. Crystal form of fludarabine phosphat, preparation method therefor, and application thereof
CN109265505A (zh) * 2018-09-12 2019-01-25 连云港杰瑞药业有限公司 一种磷酸氟达拉滨异构体杂质的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756704A (fr) 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
US4188378A (en) * 1978-01-04 1980-02-12 The United States Of America As Represented By The Department Of Health, Education And Welfare Anticancer and antiviral activity of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4357324A (en) * 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
DE3323621A1 (de) 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US5110919A (en) * 1989-12-04 1992-05-05 Ash Stevens, Inc. Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates
ATE169631T1 (de) * 1990-06-27 1998-08-15 Ash Stevens Inc Verfahren zur herstellung von 9-beta-d- arabinofuranosyl-2-fluoroadenin 5'-phosphaten
US5602246A (en) 1992-11-25 1997-02-11 Schering Aktiengesellschaft Process for the preparation of fludarabine or fludarabine phosphate from guanosine
FR2701027B1 (fr) * 1993-02-01 1997-07-18 Warner Lambert Co Procede de synthese ameliore du 9-(beta-d-arabinofuranosyl)adenine 5'-phosphate.
DE19543052A1 (de) * 1995-11-06 1997-05-07 Schering Ag Verfahren zur Herstellung und Reinigung von Fludarabin-Phosphat und die Verwendung von sauren Ionenaustauschern im Verfahren
IT1276126B1 (it) 1995-11-14 1997-10-27 Archimica Spa Procedimento per la preparazine di 9-((2-idrossietossi)metil) guanina
DE59807096D1 (de) 1997-12-11 2003-03-06 Schering Ag Verfahren zur herstellung von fludarabin-phosphat-lithium-, natrium-, kalium-, calcium- und magnesium-salzen, reinigungsverfahren zur herstellung von fludarabin-phosphat und fludarabin-phosphat mit mindestens 99,5 %iger reinheit
US6174873B1 (en) 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs

Also Published As

Publication number Publication date
AU739574B2 (en) 2001-10-18
HK1033831A1 (en) 2001-09-28
WO1999029710A3 (de) 1999-09-10
ATE231880T1 (de) 2003-02-15
EP1047704B1 (de) 2003-01-29
ES2190136T3 (es) 2003-07-16
PL341659A1 (en) 2001-04-23
SK8872000A3 (en) 2001-03-12
AU2155099A (en) 1999-06-28
IL136283A0 (en) 2001-05-20
CZ296366B6 (cs) 2006-02-15
HU226997B1 (en) 2010-04-28
JP2009040797A (ja) 2009-02-26
JP4261051B2 (ja) 2009-04-30
JP2001525418A (ja) 2001-12-11
DE59807096D1 (de) 2003-03-06
SK283475B6 (sk) 2003-08-05
CA2313486A1 (en) 1999-06-17
ES2190136T5 (es) 2008-03-01
HUP0100169A3 (en) 2002-04-29
AT8617U1 (de) 2006-10-15
KR100532898B1 (ko) 2005-12-05
EP1047704A2 (de) 2000-11-02
SI1047704T1 (en) 2004-02-29
EP1047704B2 (de) 2007-11-07
WO1999029710A2 (de) 1999-06-17
DE29825173U1 (de) 2005-12-22
NO20002962D0 (no) 2000-06-09
ZA9811338B (en) 1999-06-10
IL136283A (en) 2006-10-31
PL195712B1 (pl) 2007-10-31
HUP0100169A1 (hu) 2001-11-28
KR20050085937A (ko) 2005-08-29
US7547776B1 (en) 2009-06-16
CZ20002159A3 (cs) 2000-09-13
NO315324B1 (no) 2003-08-18
SI1047704T2 (sl) 2008-02-29
KR20010032919A (ko) 2001-04-25
DK1047704T4 (da) 2008-03-25
US6046322A (en) 2000-04-04
NO20002962L (no) 2000-06-09
TW424093B (en) 2001-03-01

Similar Documents

Publication Publication Date Title
EP0780370A3 (de) Verfahren zur Herstellung von D,L-Methionin oder dessen Salzen
ZA931376B (en) Production of purified calcium carbonate.
NO994466D0 (no) Krystallinsk aminsalt av cefdinir
MXPA03006001A (es) Derivados de fosfonato de nucleosido aciclico novedoso, sales de estos y proceso para la preparacion de los mismos.
DK1047704T3 (da) Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%
DE3571550D1 (en) Pharmaceutical preparation containing a combination of nitrendipin and enalapril and process for its preparation
DK1302207T3 (da) Fremgangsmåde til at fremstille et antihypertensivt middel indeholdende et dipeptid som virkningsfuld bestanddel
NO20005121D0 (no) FremgangsmÕte for fremstilling av kaliumsulfat
FR2717387B1 (fr) Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline.
EP0830325A4 (en) PROCESS FOR SLOWING THE SETTING SPEED OF MAGNESIUM PHOSPHATE CEMENTS
DK0840724T3 (da) Fremgangsmåde til fremstilling af enantiomerisk ren azetidin-2-caboxylsyre
IS4860A (is) Bætt aðferð til að framleiða enantíómerískt hreina asetidín-2-karboxýlsýru
DE69704933D1 (de) Mikroporöse kristalline metallphosphate
EE03934B1 (et) Enantiomeerselt rikastatud N-derivaaditud laktaamide valmistamismeetod
NZ318374A (en) Method for the production of magnesium pyridoxal-5'-phosphate glutamate
YU28999A (sh) Postupak za kristalisanje derivata tetrahidropiridina i dobijeni kristalni oblici
FI973836A0 (fi) Enfasig gipsbaeddsprocess foer produktion av kaliumsalter
FR2778127B1 (fr) Procede de fraisage comportant un retournement de la piece fraisee
BR9809286A (pt) Processos para redução de fibrinogênio
FR2712214B1 (fr) Procédé de cristallisation des déchets.
PL346536A1 (en) Process for the preparation of calcium hydroxyalkane sulphonates
FR2743504B3 (fr) Elements de construction tridimensionnels emboitables, procede de realisation et application a la realisation d'un puzzle
ES1033791Y (es) Hilera para la produccion de ladrillos.
AUPO646097A0 (en) Production of potassium and calcium salts from saline wastewaters
ZA997742B (en) "A method of performing a system reverse engineering process".